About
Dr. Anoop is a Hematologist and Pediatric Hemato-Oncologist, providing tertiary referral services for malignant hematology (adults & children), non-malignant hematology (adults & children) and solid tumors (children). He is an active member of many professional bodies including Indian Academy of Pediatrics (IAP), British Society for Hematology (BSH), Royal College of Pediatrics& Child Health (RCPCH), Royal College of Pathologists (RCPath) and European Hematology Association (EHA). He has presented topics at recent scientific meetings on lymphoma (Lugano, Switzerland), leukemia (London, UK), stem cell mobilization (Baltimore, USA), autoimmune hemolytic anemia (Guildford, UK) and clinical trials (Oslo, Norway).
Experience
Dr. Anoop is a UK-trained Hematologist and Pediatric Hemato-Oncologist with clinical experience from globally reputed Hemato-Oncology centers in London including Royal Marsden Hospital, St George's Hospital and Great Ormond Street Hospital. After completion of MBBS degree and MD in Pediatrics from Kerala, Dr. Anoop went abroad to pursue higher specialist training in Hemato-Oncology. He worked in the UK for 9 years, of which most of the time was spent in London. Additionally, he has also worked short stints at Warwickshire and Derbyshire. He has trained under and worked with many internationally renowned experts in Hematology and Oncology.
Special Interests
Blood disorders in adults and children
Solid organ cancers in children
Pediatric haemato-oncology
Cancer research
Awards and Achievements
- Dr.Anoop. P was awarded Fellowship in Clinical Hematology in 2010 by The Royal College Of Pathologists, London, United Kingdom.
- Dr.Anoop. P was awarded Membership in Pediatrics in 2006 and Fellowship in PediatricHemato-Oncology in 2014 by The Royal College Pediatrics and Child Health, London, United Kingdom, in 2014.
- Fulminant hepatic failure due to reactivation of hepatitis C following treatment of chronic lymphocytic leukemia with alemtuzumab; 3rd prize for oral presentation;London Deanery School of Pathology annual conference, Royal College of Pathology, London, United Kingdom, March 2010. This study was later published in British Journal of Hematology.
- Results of the United Kingdom national multicentric analysis of the outcome of relapsed mature B-cell Non-Hodgkin's lymphoma in children; oral presentation; International Conference on Malignant Lymphoma, Lugano, Switzerland, June 2011.This work was subsequently published in Leukemia and Lymphomajournal.
- The role of plerixafor as a second line stem cell mobilizing agent in children; poster presentation; 22nd annual conference of American Society of Pediatric Hematology and Oncology (ASPHO); Baltimore, USA, April 2011. Published later in the Journal of Pediatric Hematology and Oncology.
Research and Publications
Dr. Anoop possesses a rich academic profile with over 50 publications in reputed international medical journals indexed by Medline/PubMed (the complete list of publications to date is available from:http://www.ncbi.nlm.nih.gov/pubmed?term=%22Anoop%20P%22%20%5BAuthor%5D). In addition, he is a reviewer for journals such as Hematology, Pediatric Hematology & Oncology, International Journal of Laboratory Hematology, Indian Pediatrics and Journal of Pediatric Hematology & Oncology. Some of hisrecent and frequently cited publications include:
Anoop P, Sankpal S, Stiller C, Tewari S, Lancaster DL, Khabra K, Taj MM. Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia. Leuk Lymphoma. 2012 Oct; 53(10): 1882-1888.
Anoop P. Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.Indian Pediatr. 2012 Oct; 49(10): 811-818.
Anoop P, Lancaster DL, Rassam SM, Atra A. Florid erythroid dysplasia mimicking congenital dyserythropoietic anemia during the preleukemic phase of acute erythroleukemia. Pediatr Hematol Oncol. 2012 Mar; 29(2): 173-175.
Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. Hematology. 2011 Jul; 16(4): 213-220.
Anoop P, Lancaster DL, Atra A. Osteolytic presentation of pediatric acute megakaryoblasticleukemia.PediatrHematolOncol. 2011 Sep;28(6):526-528.
Islam MS, Anoop P, Datta-Nemdharry P, Sage D, Gordon-Smith EC, Turner D, Wiltshire S, O'Regan L, Marsh JC. Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia. Bone Marrow Transplant. 2010 May; 45(5): 886-894.
Addada J, Anoop P, Swansbury JG, Wotherspoon A, Thomas JM, Matutes E. Synchronous mantle cell lymphoma, chronic lymphocytic leukaemia and melanoma in a single lymph node. Acta Haematol. 2010 Mar; 123(3): 194-196.
Anoop P, Ravindranathan G, Osuji N, Dearden CE, Wotherspoon A, Bain BJ, Matutes E. Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia. Br J Haematol. 2010 Jan; 148(2): 337-339.
Anoop P. Near total effacement of bone marrow by medulloblastoma. Am J Hematol. 2010 Feb; 85(2): 128.
Anoop P. Variations in the treatment threshold for immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009 Mar; 52(3): 429.
Anoop P, Hargrave D, Zacharoulis S, Saran F. Diagnostic and therapeutic challenges owing to concurrent pontineglioma and acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008 Jun; 30(6):454-457.
Anjay MA, Anoop P, Britland A. Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection. Arch Dis Child. 2007 Sep; 92(9): 820-823.
+91-9599966306